Cover Image

March 26, 2001

Vol.184 / No.10

March 26, 2001

Paul LauritzenMarch 26, 2001

In his testimony before the National Bioethics Advisory Commission on stem cell research, Gilbert Meilaender urged the commission to be honest in its recommendations. If you endorse federal funding of stem cell research, he said, don’t do so by pretending that an unimplanted embryo is not an e

Lisa Sowle CahillMarch 26, 2001

Some day medical science may be able to heal or alleviate ailments like Alzheimer’s disease, Parkinson’s disease, diabetes, spinal cord injuries, heart disease and cancer by giving patients new cells that have been guided to act as replacements for their own damaged tissue. Sometimes the

Michael D. PlaceMarch 26, 2001

Every Christmas, through the miracle to which we bear witness, we are reminded of life’s infinite possibilities. In this context, we enter each new year with a sense of renewed hope and opportunity. We see afresh the potential for achieving good and righting wrongs in our lives, in our communi

Peter ChiricoMarch 26, 2001

Dominus Iesus, the declaration of Aug. 6, 2000, of the Congregation for the Doctrine of the Faith, has received myriad interpretive responses. This article is not an attempt to add to these. Rather, I shall consider Dominus Iesus as more than a document. I propose to consider it, along with various

Of Many Things
George M. AndersonMarch 26, 2001

Snapshots play a part in the lives of many of ussmall pictures of family groups, children, friends, co-workers. You find them not just at home, but in the workplace too, as well as in wallets and purses. On my way to work on the subway, or going home in the evening, I sometimes see passengers sharin

Letters
Our readersMarch 26, 2001

Beacons of Hope

Your editorial Saying No to Israel (3/5) provides a beacon of hope for the many who have raised protests in this Holy Land against the Israeli occupation, protests that rarely surface in Western media. These protests have come from Israelis and Palestinians, from

Editorials
The EditorsMarch 26, 2001

Through Medicaid and other programs, most poor people in the United States have access to the new AIDS drug therapies. But in developing countries, their cost—over $10,000 a year—has made their use all but impossible. As a result, the AIDS pandemic has widened its devastating scope in bo